Vanguard Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Other funds holding RYTM
BBA
Vanguard Asset Management's RYTM Position: Q3 2026 in Review
Vanguard Asset Management increased its Rhythm Pharmaceuticals (RYTM) stake by 6.3% in Q3 2026, buying an estimated $358K and bringing the position to 56,631 shares worth $5.39M. The position accounts for ﹤0.01% of the portfolio, ranked #995.
Vanguard Asset Management first reported a position in RYTM in Q1 2026 and has held it in 3 quarters since. The position peaked at $5.92M in Q2 2026. 329 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.
- Vanguard Asset Management held 56,631 shares of Rhythm Pharmaceuticals worth $5.39M as of Q3 2026.
- Vanguard Asset Management bought 3,352 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $358K.
- Rhythm Pharmaceuticals made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #995 holding.
- Vanguard Asset Management first reported a position in Rhythm Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- Vanguard Asset Management's Rhythm Pharmaceuticals position peaked at $5.92M in Q2 2026.
- 329 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.
Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.